| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |